Monoclonal immunoglobulin crystalline nephropathies
Kidney International · 2024-08 · 106 (2) · 201-213
DOI: 10.1016/j.kint.2024.02.027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney International, 2024-08. Verfasst von Samih H Nasr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Nasr.samih@mayo.edu. Hauptthemen laut MEDLINE: Crystallization, Kidney Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 106 Literaturangaben.
Abstract (Originalsprache)
Monoclonal Ig crystalline nephropathies are rare lesions resulting from precipitation of monoclonal Igs in the kidney as crystalline inclusions. They can be categorized into lesions with predominant intracellular crystals (light chain [LC] proximal tubulopathy, LC crystal-storing histiocytosis, and LC crystalline podocytopathy) and lesions with predominant extracellular crystals (crystalglobulin-induced nephropathy and crystalline variant of LC cast nephropathy). The majority of these lesions are associated with low tumor burden lymphoproliferative disorders, with the exception of crystalline variant of LC cast nephropathy. Extrarenal involvement (e.g., skin and cornea) is frequent. Kidney biopsy is the cornerstone for diagnosis, which often requires electron microscopy and antigen retrieval. A thorough hematologic workup and evaluation of extrarenal involvement is mandatory for management. Treatment of these lesions is with clone-directed therapy, with the goal of achieving hematologic very good partial response or complete response, which preserves or improves kidney function. In vitro and in vivo studies, animal models, and novel sequencing techniques have been invaluable tools to understand the pathogenesis of LC proximal tubulopathy and can be used to increase our limited knowledge of the pathogenesis of the other monoclonal Ig crystalline nephropathies. This review provides an update on the pathology, renal and hematologic characteristics, extrarenal manifestations, prognosis, treatment, and pathogenesis of monoclonal Ig crystalline nephropathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Nasr.samih@mayo.edu.
- Control of the Immune Response B and Lymphoproliferation, Joint Research Unit CNRS 7276, INSERM 1262, University of Limoges, Limoges, France; Centre de Référence de l'Amylose AL et des autres Maladies par Dépôts d'Imuno…
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Zitieren
APA
Nasr, S. H., Sirac, C., Leung, N., & Bridoux, F. (2024). Monoclonal immunoglobulin crystalline nephropathies. Kidney International, 106(2), 201-213. https://doi.org/10.1016/j.kint.2024.02.027
Vancouver
Nasr SH, Sirac C, Leung N, Bridoux F. Monoclonal immunoglobulin crystalline nephropathies. Kidney International. 2024;106(2):201-213. doi:10.1016/j.kint.2024.02.027
BibTeX
@article{Nasr2024,
author = {Nasr, Samih H and Sirac, Christophe and Leung, Nelson and Bridoux, Frank},
title = {Monoclonal immunoglobulin crystalline nephropathies},
journal = {Kidney International},
year = {2024},
volume = {106},
number = {2},
pages = {201--213},
doi = {10.1016/j.kint.2024.02.027}
}
EUVIMED